ScanSource Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

ScanSource (SCSC) reported strong Q4 fiscal 2025 results, with adjusted EPS of $1.02, up 28% year-over-year, and revenues of $813 million, up 8.9%, both exceeding analyst consensus and driven by robust North American growth. The company also issued an optimistic fiscal 2026 outlook, forecasting revenues of $3.1-$3.3 billion and adjusted EBITDA of $150-$160 million. This positive performance and forward guidance come as the stock has underperformed its industry, losing 8.7% over the past year.

Analysis

ScanSource, Inc. (SCSC) delivered a strong fourth-quarter fiscal 2025 performance, significantly exceeding consensus estimates with an adjusted EPS of $1.02, a 28% year-over-year increase, and quarterly revenues of $813 million, up 8.9% year-over-year. This top-line growth was almost entirely fueled by its North American operations, which saw a 12.2% revenue increase to $745 million, effectively masking a notable 17.4% decline in international sales. Despite a marginal compression in gross margin to 12.9%, the company improved its adjusted EBITDA margin to 4.7% from 4.6% a year prior, indicating effective cost management. This robust quarterly result contrasts with the full fiscal year 2025 performance, where total revenues declined 6.7%, suggesting Q4 marks a significant positive inflection point. Management's confidence in this turnaround is reflected in its strong fiscal 2026 guidance, projecting revenues between $3.1-$3.3 billion and adjusted EBITDA of $150-$160 million. However, a key point of concern is the substantial year-over-year decrease in cash from operating activities for fiscal 2025, which fell to $112 million from $372 million in the prior year. This financial metric, combined with the stock's 8.7% loss over the past year against an 18% industry gain, creates a complex picture of operational outperformance coupled with market skepticism and weakening cash generation.

Key Decisions for Investors

• Given the strong Q4 earnings beat and robust FY26 guidance, investors may view the stock's 8.7% year-over-year underperformance as a potential value opportunity, contingent on the company sustaining its North American momentum.
• The significant 17.4% decline in international sales warrants close monitoring, as continued weakness in this segment could pose a material risk to achieving the optimistic full-year revenue guidance.
• The sharp reduction in operating cash flow in FY25 is a primary concern; investors should scrutinize upcoming quarterly reports for a clear rebound in cash generation to validate the sustainability of the turnaround and support the company's projected free cash flow.
• Consider the mixed results from peers MSM, SITE, and GWW, which suggest a challenging macro environment, making SCSC's North American outperformance a key differentiator that needs to be sustained.